Literature DB >> 23683157

Association between high serum total bilirubin and post-stroke depression.

Wai Kwong Tang1, Huajun Liang, Winnie Chiu Wing Chu, Vincent Mok, Gabor S Ungvari, Ka Sing Wong.   

Abstract

AIM: High serum bilirubin predicts depression in non-stroke subjects, but it is unknown whether it also predicts post-stroke depression (PSD). This study examined the association between the risk of PSD and bilirubin level.
METHODS: Six hundred and thirty-five patients with acute ischemic stroke in Hong Kong were recruited. Serum total bilirubin, alanine transaminase and alkaline phosphatase levels were measured in all patients during their hospital stay. A psychiatrist gave the Structured Clinical Interview for DSM-IV to all patients 3 months after the index stroke, with 61 patients diagnosed with PSD: 27 with major depression, 24 with minor depression and 10 with dysthymia.
RESULTS: In the full sample, the 25%, 50% and 75% percentile bilirubin levels were 7.0, 10.0 and 14.0 μmol/L, respectively. Significant differences were found between the PSD and non-PSD groups in terms of bilirubin level (P = 0.006). In post-hoc comparisons, the proportion of patients with bilirubin ≥14.1 μmol/L was significantly higher in the PSD group (37.7% vs 19.7%, P = 0.001). In the final regression model, bilirubin level (≥14.1 μmol/L) remained a significant independent predictor of PSD, with an odds ratio of 2.4.
CONCLUSIONS: High bilirubin level is associated with PSD. Further investigations are needed to clarify the underlying pathophysiological link between bilirubin level and PSD.
© 2013 The Authors. Psychiatry and Clinical Neurosciences © 2013 Japanese Society of Psychiatry and Neurology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23683157     DOI: 10.1111/pcn.12051

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  10 in total

Review 1.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

Review 2.  Neuropsychiatric sequelae of stroke.

Authors:  José M Ferro; Lara Caeiro; Maria Luísa Figueira
Journal:  Nat Rev Neurol       Date:  2016-04-11       Impact factor: 42.937

3.  Post-Stroke Depression and Estimated Glomerular Filtration Rate: A Prospective Stroke Cohort.

Authors:  Shasha Lin; Xiaoqian Luan; Weilei He; Yiting Ruan; Chengxiang Yuan; Aiyue Fan; Xiachan Chen; Jincai He
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-21       Impact factor: 2.570

4.  Poststroke depression as a factor adversely affecting the level of oxidative damage to plasma proteins during a brain stroke.

Authors:  Natalia Cichoń; Michał Bijak; Elżbieta Miller; Marta Niwald; Joanna Saluk
Journal:  Oxid Med Cell Longev       Date:  2015-03-08       Impact factor: 6.543

Review 5.  Poststroke Depression Biomarkers: A Narrative Review.

Authors:  Oleg A Levada; Alexandra S Troyan
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

6.  The association between serum albumin and depression in chronic liver disease may differ by liver histology.

Authors:  Junyan Cao; Weihong Qiu; Yong Yu; Na Li; Huixiang Wu; Zhaocong Chen
Journal:  BMC Psychiatry       Date:  2022-01-04       Impact factor: 3.630

7.  Blood biomarkers of post-stroke depression after minor stroke at three months in males and females.

Authors:  Zhou Zhu; Suiqiang Zhu; Xiuli Qiu; He Wang; Yan Lan; Jinfeng Miao; Chensheng Pan; Wenzhe Sun; Guo Li; Yanyan Wang; Xin Zhao
Journal:  BMC Psychiatry       Date:  2022-03-03       Impact factor: 3.630

8.  Nomogram for Persistent Post-Stroke Depression and Decision Curve Analysis.

Authors:  Yan Lan; Chensheng Pan; Xiuli Qiu; Jinfeng Miao; Wenzhe Sun; Guo Li; Xin Zhao; Zhou Zhu; Suiqiang Zhu
Journal:  Clin Interv Aging       Date:  2022-04-05       Impact factor: 4.458

9.  Serum profile changes in postpartum women with a history of childhood maltreatment: a combined metabolite and lipid fingerprinting study.

Authors:  Alexandra M Koenig; Alexander Karabatsiakis; Thomas Stoll; Sarah Wilker; Thomas Hennessy; Michelle M Hill; Iris-Tatjana Kolassa
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

10.  Chronic stress and antidepressant treatment alter purine metabolism and beta oxidation within mouse brain and serum.

Authors:  Peter J Hamilton; Emily Y Chen; Vladimir Tolstikov; Catherine J Peña; Joseph A Picone; Punit Shah; Kiki Panagopoulos; Ana N Strat; Deena M Walker; Zachary S Lorsch; Hannah L Robinson; Nicholas L Mervosh; Drew D Kiraly; Rangaprasad Sarangarajan; Niven R Narain; Michael A Kiebish; Eric J Nestler
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.